Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Christopher Cassella

ID: 1b83bbcc-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Hikma Launches Denosumab Biosimilars ENOBY and XTRENBO

Big Molecule Watch · February 10, 2026

Genentech/Hoffmann La-Roche and Shanghai Henlius Biotech/Organon Settle Pertuzumab BPCIA Case

Big Molecule Watch · February 5, 2026

Sandoz Launches Natalizumab Biosimilar

Big Molecule Watch · November 24, 2025

FDA Approves Accord BioPharma’s Denosumab Biosimilars

Big Molecule Watch · November 21, 2025

FDA Grants Interchangeability Designation to Fresenius Kabi’s and Celltrion’s Denosumab Biosimilars

Big Molecule Watch · October 30, 2025

Previous

12 3 4

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog